13D/13G Filings - Werewolf Therapeutics Inc. (HOWL)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-05-14
4:42 pm
Purchase
2021-05-04 13G Werewolf Therapeutics, Inc.
HOWL
Longwood Fund III GP LLC 1,677,082
6.100%
1,677,082increase
(New Position)
Filing
History
2021-05-13
4:30 pm
Purchase
2021-05-04 13D Werewolf Therapeutics, Inc.
HOWL
Taiho Ventures LLC 2,068,909
7.510%
2,068,909increase
(New Position)
Filing
History
2021-05-10
11:21 am
Purchase
2021-04-29 13D Werewolf Therapeutics, Inc.
HOWL
Moshe Arkin 2,046,634
7.400%
2,046,634increase
(New Position)
Filing
History
2021-05-06
4:33 pm
Purchase
2021-05-04 13D Werewolf Therapeutics, Inc.
HOWL
RA Capital Management, L.P. 3,968,583
14.400%
3,968,583increase
(New Position)
Filing
History
2021-05-04
12:33 pm
Purchase
2021-05-04 13G Werewolf Therapeutics, Inc.
HOWL
Flynn James E 2,552,787
9.270%
2,552,787increase
(New Position)
Filing
History
Goto Prev, 0, 1